Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P850010/S119

Helistat Absorbable Collagen Hemostatic Agent and Helitene Absorbable Collagen Hemostatic Agent- Fibrillar Form

Integra LifeSciences Corporation · Decision date Sep 18, 2026

MEDTECHLEDGER EXPLANATIONP850010/S119

What did the FDA decide?

This 30-Day Notice for PMA supplement P850010/S119 covers Integra LifeSciences Corporation's Helistat and Helitene absorbable collagen hemostatic agents. The stated change is the installation and qualification of a new Water for Injection pretreatment, generation, storage, and distribution system.

The supplement type is a process change involving manufacturer, sterilizer, packager, or supplier. The FDA decision field shows OK30, dated 2026-09-18. The notice does not describe clinical testing, safety outcomes, or effectiveness data. Specific details about equipment location, validation protocols, or acceptance criteria are absent from the supplied fields.

FDA approval order statement

installation and qualification of a new Water for Injection (WFI) pretreatment, generation, storage, and distribution system
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
General, Plastic Surgery
Decision date
Sep 18, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P850010/S119
Regulatory pathway
PMA supplement
Product code
LMF
Decision code
OK30
Decision date
Sep 18, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Agent, absorbable hemostatic, collagen based.

Product code
LMF
FDA device class
3

For the original device and its historical approval scope, see PMA P850010. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P850010 · Original PMA

    HELISTAT(TM) ABSORBABLE COLLAGEN HEMOSTATIC SPONGE

  2. P850010/S119 received

    Application receipt date recorded by FDA.

  3. P850010/S119 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P850010. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P850010

Product / regulatory recordCompanyPathwayDecision dateSource
Integra LifeSciences CorporationPMA approvalNov 8, 1985FDA

Explore the linked device profile

Other records with product code LMF

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Integra LifeSciences Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
311 Enterprise Dr., Plainsboro, NJ, 08540

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records